BioCentury | Aug 1, 2019
Product Development

NeuBase takes antisense oligos to more targets in more places

...components of PATrOL springboard off work by NeuBase’s scientific founder and CSO Danith Ly at Carnegie...
...Pharma Ltd., Surrey, U.K. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Expansion Therapeutics Inc., San Diego, Calif. Carnegie...
...kinase GSK3B - Glycogen synthase kinase 3 beta HTT - Huntingtin Allison Johnson, Senior Writer IONIS-HTTRx, RG6042, isis-httrx WVE-120101 WVE-120102 Carnegie...
BioCentury | Jul 26, 2019
Company News

Management tracks: Obsidian builds out team; plus Agilvax, Selvita, NeuBase and more

...professor of chemistry and a founding director of the Biomolecular Design and Discovery Institute at Carnegie...
BioCentury | Oct 4, 2018
Tools & Techniques

Lilly: academic about manufacturing

...ties with two academic centers to meet an array of engineering challenges. Through partnerships with Carnegie...
...a virtual lab dedicated to manufacturing solutions. Lilly also has a manufacturing research collaboration with Carnegie...
...engineering problems; now pharma’s more willing to talk with engineers.” Nikolaos Sahinidis, Carnegie Mellon University Carnegie...
BioCentury | Aug 30, 2018
Tools & Techniques

Master of autism

...Howard Hughes Medical Institute investigator and director emeritus of the department of embryology at the Carnegie...
...Howard Hughes Medical Institute investigator and director emeritus of the department of embryology at the Carnegie...
...could step in to counteract the effects of a CPEB4-targeted therapy. Companies and Institutions Mentioned Carnegie...
BioCentury | Nov 3, 2017
Financial News

BioArctic prices SSE IPO

...sale of 29.2 million shares at SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie...
BioCentury | Jun 23, 2017
Financial News

BoneSupport raises SEK500M in IPO

...million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie...
BioCentury | Jun 21, 2017
Financial News

BoneSupport rises after SEK500M IPO

...million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie...
BioCentury | Apr 22, 2017
Finance

Sweden heating up

...to list themselves. We have a backlog that stretches to the end of 2017,” noted Carnegie...
...the game.” BioCentury (2003) Amran Gowani, Senior Editor, Research & Analytics Ascendis Pharma A/S Biogen Inc. Braeburn Pharmaceuticals Inc. Camurus AB Carnegie...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie...
Items per page:
1 - 10 of 165
BioCentury | Aug 1, 2019
Product Development

NeuBase takes antisense oligos to more targets in more places

...components of PATrOL springboard off work by NeuBase’s scientific founder and CSO Danith Ly at Carnegie...
...Pharma Ltd., Surrey, U.K. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Expansion Therapeutics Inc., San Diego, Calif. Carnegie...
...kinase GSK3B - Glycogen synthase kinase 3 beta HTT - Huntingtin Allison Johnson, Senior Writer IONIS-HTTRx, RG6042, isis-httrx WVE-120101 WVE-120102 Carnegie...
BioCentury | Jul 26, 2019
Company News

Management tracks: Obsidian builds out team; plus Agilvax, Selvita, NeuBase and more

...professor of chemistry and a founding director of the Biomolecular Design and Discovery Institute at Carnegie...
BioCentury | Oct 4, 2018
Tools & Techniques

Lilly: academic about manufacturing

...ties with two academic centers to meet an array of engineering challenges. Through partnerships with Carnegie...
...a virtual lab dedicated to manufacturing solutions. Lilly also has a manufacturing research collaboration with Carnegie...
...engineering problems; now pharma’s more willing to talk with engineers.” Nikolaos Sahinidis, Carnegie Mellon University Carnegie...
BioCentury | Aug 30, 2018
Tools & Techniques

Master of autism

...Howard Hughes Medical Institute investigator and director emeritus of the department of embryology at the Carnegie...
...Howard Hughes Medical Institute investigator and director emeritus of the department of embryology at the Carnegie...
...could step in to counteract the effects of a CPEB4-targeted therapy. Companies and Institutions Mentioned Carnegie...
BioCentury | Nov 3, 2017
Financial News

BioArctic prices SSE IPO

...sale of 29.2 million shares at SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie...
BioCentury | Jun 23, 2017
Financial News

BoneSupport raises SEK500M in IPO

...million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie...
BioCentury | Jun 21, 2017
Financial News

BoneSupport rises after SEK500M IPO

...million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie...
BioCentury | Apr 22, 2017
Finance

Sweden heating up

...to list themselves. We have a backlog that stretches to the end of 2017,” noted Carnegie...
...the game.” BioCentury (2003) Amran Gowani, Senior Editor, Research & Analytics Ascendis Pharma A/S Biogen Inc. Braeburn Pharmaceuticals Inc. Camurus AB Carnegie...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie...
Items per page:
1 - 10 of 165